About
replimune group, inc., a biotechnology company, develops oncolytic immune-gene therapies to treat cancer. it uses its proprietary immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. th
CEOphilip Astley-Sparke
HQWoburn, Massachusetts
Employees244